ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways

Ruiz-Vela, Antonio*; Aggarwal, Mohit; de la Cueva, Palorna; Treda, Cezary; Herreros, Beatriz; Martfn-Perez, Daniel; Dominguez, Orlando; Piris, Miguel A.
Blood2008-2-1DOI: 10.1182/blood-2007-09-110601
17被引1阅读
引用收藏
分享

摘要

Aberrant inhibition of B-cell receptor (BCR)-induced programmed cell death pathways is frequently associated with the development of human auto-reactive B-cell lymphomas. Here, we integrated loss-of-function, genomic, and bioinformatics approaches for the identification of oncogenic mechanisms linked to the inhibition of BCR-induced clonal deletion pathways in human B-cell lymphomas. Lentiviral (HIV)-based RNA interference screen identified MCL1 as a key survival molecule linked to BCR signaling. Loss of MCL1 by RNA interference rendered human B-cell lymphomas sensitive to BCR-induced programmed cell death. Conversely, MCL1 overexpression blocked programmed cell death on BCR stimulation. To get insight into the mechanisms of MCL1 -induced survival and transformation, we screened 41 000 human genes in a genome-wide gene expression profile analysis of MCL1-overexpressing B-cell lymphomas. Bioinformatic gene network reconstruction illustrated reprogramming of relevant oncoproteins within beta-catenin-T-cell factor signaling pathways induced by enforced MCL1 expression. Overall, our findings not only illustrate MCL1 as an aberrantly expressed reprogramming oncoprotein in follicular lymphomas but also highlight MCL1 as key therapeutic target.

学科与关键词

关键词
NON-HODGKINS-LYMPHOMASANTIGEN-RECEPTORFOLLICULAR LYMPHOMAANTIAPOPTOTIC MCL-1INDUCED APOPTOSISSYSTEMS BIOLOGYTYROSINE KINASEGENE-EXPRESSIONSUBSTRATE PARPT-LYMPHOCYTES
相关
加载中…
  • Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy
    Peng-Ju Zhu; Ze-Zhou Yu; Qi-Dong You; Zheng-Yu JiangDrug Discovery Today, 2020, 25(10): 1873-1882.
  • High-Expressed CXCR7 Contributes to CXCL12-Mediated Protection from Apoptosis in Lymphoma Cells
    Dongsheng, Xu; Xiaobei, DengJournal of Molecular and Genetic Medicine, 2016, 10(2).
  • Novel Pharmacotherapies for B-Cell Lymphomas and Leukemias
    Michael T , Tees; Lubomir, SokolAMERICAN JOURNAL OF THERAPEUTICS, 2016, 23(2): e498-e520.
查看全部 →

发表信息

论文状态
公开发表
期刊
Blood
发表日期
2008-02-01
卷期
第 111 卷, 第 3 期
页码
1665-1676
DOI
10.1182/blood-2007-09-110601
语言
ENGLISH
成果收录
SCIE

作者

  • R

    Ruiz-Vela, Antonio (通讯) (第一作者)

  • A

    Aggarwal, Mohit

查看全部 8 位作者收起作者
  • d

    de la Cueva, Palorna

  • T

    Treda, Cezary

  • H

    Herreros, Beatriz

  • M

    Martfn-Perez, Daniel

  • D

    Dominguez, Orlando

  • P

    Piris, Miguel A.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417